Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR

Wolf, Sebastian; Holz, Frank G; Korobelnik, Jean-François; Lanzetta, Paolo; Mitchell, Paul; Prünte, Christian; Schmidt-Erfurth, Ursula; Weichselberger, Andreas; Hashad, Yehia (2011). Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR. British journal of ophthalmology, 95(12), pp. 1713-8. London: BMJ Publishing Group 10.1136/bjophthalmol-2011-300471

Full text not available from this repository. (Request a copy)

This study aims to assess the impact of continued ranibizumab treatment for neovascular age-related macular degeneration on patients from the MARINA and ANCHOR randomised clinical studies who lost ≥ 3 lines of best-corrected visual acuity (BCVA) at any time during the first year of treatment.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Wolf, Sebastian

ISSN:

0007-1161

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:16

Last Modified:

17 Mar 2015 19:20

Publisher DOI:

10.1136/bjophthalmol-2011-300471

PubMed ID:

21951567

Web of Science ID:

000297261700020

URI:

https://boris.unibe.ch/id/eprint/4537 (FactScience: 208813)

Actions (login required)

Edit item Edit item
Provide Feedback